{"DataElement":{"publicId":"7502573","version":"1","preferredName":"Clinical Study Subgroup Assignment Code","preferredDefinition":"The coded response for the study subgroup a participant is assigned to.","longName":"SGCODE","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7502572","version":"1","preferredName":"Clinical Study Subgroup Assignment","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._A subdivision of a larger group with members often exhibiting similar characteristics._An allotting or an appointment to a particular person or use, or for a particular time or object.","longName":"7502670v1.0:2454524v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"7502670","version":"1","preferredName":"Clinical Study Subgroup","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.:A subdivision of a larger group with members often exhibiting similar characteristics.","longName":"C15206:C25693","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3F07A67-753F-6ECF-E053-4EBD850AB5A6","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"ONEDATA","dateModified":"2020-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2454524","version":"1","preferredName":"Assignment","preferredDefinition":"Assignment; an undertaking that you have been assigned to do.","longName":"C25426","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assignment","conceptCode":"C25426","definition":"An allotting or an appointment to a particular person or use, or for a particular time or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0E070B71-91E5-1732-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-03-10","modifiedBy":"ONEDATA","dateModified":"2006-03-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3F1086A-EF60-3BDB-E053-4EBD850AAB73","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"TAYLORT","dateModified":"2020-11-16","changeDescription":"TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7502568","version":"1","preferredName":"Subgroup Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection._A subdivision of a larger group with members often exhibiting similar characteristics._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"SUBGRP_CODE","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SG2","valueDescription":"SG2: Dose Expansion","ValueMeaning":{"publicId":"7502569","version":"1","preferredName":"SG2: Dose Expansion","longName":"7502569","preferredDefinition":"A subdivision of a larger group with members often exhibiting similar characteristics.: A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.: A group of subjects in a phase I trial, usually accrued after the maximum tolerated dose maximum tolerated dose has been established. These subjects, often with additional eligibility criteria, are used to: confirm that a safe level of drug exposure has been established, obtain preliminary evidence of efficacy, and identify specific patient subgroups that might derive particular benefits from the investigational treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Two","conceptCode":"C66833","definition":"A natural number greater than 1 and less than 3 and the quantity that it denotes: the sum of one and one.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose Expansion Cohort","conceptCode":"C133188","definition":"A group of subjects in a phase I trial, usually accrued after the maximum tolerated dose maximum tolerated dose has been established. These subjects, often with additional eligibility criteria, are used to: confirm that a safe level of drug exposure has been established, obtain preliminary evidence of efficacy, and identify specific patient subgroups that might derive particular benefits from the investigational treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3FD59BD-89DB-7363-E053-4EBD850ACC0C","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"TAYLORT","dateModified":"2020-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3FD59BD-89F4-7363-E053-4EBD850ACC0C","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"ONEDATA","dateModified":"2020-11-13","deletedIndicator":"No"},{"value":"SG1","valueDescription":"SG1: Dose Escalation","ValueMeaning":{"publicId":"7502570","version":"1","preferredName":"SG1: Dose Escalation","longName":"7502570","preferredDefinition":"A subdivision of a larger group with members often exhibiting similar characteristics.: The smallest natural number and quantity it denotes: a single entity, unit, or object.: A stepwise increase in the amount of a therapeutic or investigational agent given to an individual.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"One","conceptCode":"C66832","definition":"The smallest natural number and quantity it denotes: a single entity, unit, or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose Escalation","conceptCode":"C107213","definition":"A stepwise increase in the amount of a therapeutic or investigational agent given to an individual.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3FD59BD-8A02-7363-E053-4EBD850ACC0C","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"TAYLORT","dateModified":"2020-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B3FD59BD-8A1B-7363-E053-4EBD850ACC0C","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"ONEDATA","dateModified":"2020-11-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7502567","version":"1","preferredName":"Subgroup Code","preferredDefinition":"A subdivision of a larger group with members often exhibiting similar characteristics.:A symbol or combination of symbols which is assigned to the members of a collection.","longName":"C25693:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Subgroup","conceptCode":"C25693","definition":"A subdivision of a larger group with members often exhibiting similar characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3FD59BD-89AF-7363-E053-4EBD850ACC0C","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"ONEDATA","dateModified":"2020-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3FD59BD-89C0-7363-E053-4EBD850ACC0C","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"SOKKERL","dateModified":"2020-12-03","changeDescription":"TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient Subgroup","type":"Preferred Question Text","description":"Patient Subgroup","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Patient subgroup","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3FE3EC6-E6A1-1300-E053-4EBD850A6611","latestVersionIndicator":"Yes","beginDate":"2020-11-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-11-13","modifiedBy":"TAYLORT","dateModified":"2020-11-16","changeDescription":"TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}